CD163 and Stroke: This notion is accentuated by the fact that ablation of sCD163 from stroke-derived serum was not adequate to fully rescue its capacity to support lymphocyte proliferation, inferring that there are a multitude of other soluble factors present in post-stroke peripheral circulation which have similar inhibitory effects.